Dr. Yasmeena H shares impressions from a Wegovy event where she says new doses, fresh studies and patient stories were presented.
Recap by typeshit. Post by @dr.yasmeena_h on Instagram.
Lilly's tirzepatide shot Zepbound now has FDA approval in a KwikPen format for weight management. Tap through for details on the new pen.
At the SIO congress in Palermo, specialists flagged short real-world adherence and no national reimbursement in Italy. Oral semaglutide and orforglipron are expected there in 2027.
Polish pharmacy platform GdziePoLek says, citing the manufacturer, that the first Oral Wegovy shipment should arrive soon. No exact launch date is set yet.
A short clip from Dr. Reese pushing back on the rush toward peptides as an easy shortcut, with little detail beyond that.
FitPeo frames Ozempic, Zepbound and other GLP-1s as a useful tool rather than a fix, and stresses pairing them with solid eating habits.
The cardiologist points out that nobody has settled on what microdosing a GLP-1 actually means, and she goes into it further in her Substack this week.
Loading…